Disclosed herein is a low cost, point-of-care, complex equipment-free, semi-quantitative, field-deployable LFA method and its implementing LFD platform to detect the presence, and if present the gradation of content, of endoglin in a test sample. Also disclosed are the construction of said LFD, reagents therein, and...

A lateral flow device (LFD) (100) for detecting and quantifying glycoproteins and method thereof is provided. The LFD (100) is equipped with a lateral flow immunoassay assembly (102) that integrates a sample pad (104), conjugate pad (106) with pre-impregnated gold-coated magnetic nanoparticles (GcMNPs) conjugated to...

A lateral flow assay (LFA) device (100) for detecting biomarkers for intrapartum and neonatal complications and method thereof is provided. The LFA device (100) is equipped with a lateral flow immunoassay assembly (102) that integrates a sample pad (104), conjugate release matrix (106) pre-impregnated with bio-funct...